MONMOUTH JUNCTION, N.J., Nov. 01, 2017 (GLOBE NEWSWIRE) — DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Kira Sheinerman, PhD, Chief Executive Officer, will be presenting at the 10thClinical Trials on Alzheimer’s Disease (CTAD) being held November 1-4, 2017 in Boston, MA.